Aurobindo gets USFDA nod for oral solution for AIDS drug
Aurobindo Pharma Ltd on Monday said that
it had received tentative approval from the US Food
and Drug Administration for its oral solution of the
HIV/AIDS drug Lamivudine. The tentative approval is
for 10 mg/ml of oral solution of Lamivudine, the company
said in a statement.
November 07, 2005